The goals of the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH) are to stimulate and coordinate research on rare diseases, and to support research that responds to the needs ...

Google's AI ambitions are accelerating at breakneck speed. In 2025 and early 2026 alone, the company launched Gemma 3, its latest family of open-weight foundation models, introduced MedGemma for ...